In response to the ongoing COVID-19 pandemic, Erba Mannheim has launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2.
To overcome challenges in older COVID-19 molecular tests, Erba’s Cambridge(UK)-based development team has engineered a new assay to improve detection and ease of use with a single tube multiplex mastermix, compatible with room-temperature storage and transportation.
The new assay offers 200 copies/ml LoD, using universally trusted gene targets highly specific for SARS-CoV-2 and updated primer sequences to maximise long term performance. Sample types include both nasopharyngeal and oropharyngeal swabs as well as saliva.
Nikhil Vazirani, MD of Erba, said: “We are proud and excited to add a highly sensitive RT-PCR test to our growing range of immunoassay and molecular solutions. The new ErbaMDx SARS-CoV-2 test perfectly complements our successful COVID-19 IgG and IgM ELISA assays to offer customers a state-of-the-art molecular test in addition to antibody testing which will offer clinicians valuable insight into the immune response to infection or vaccination.”
The CE-marked kit will be available through Erba’s global distribution network.
Erba Mannheim, established in over 100 countries, focusses on delivering innovative, affordable and sustainable diagnostic solutions to labs everywhere. The Erba group uses a combination of cutting-edge R&D in 4 continents with efficient low-cost manufacturing to make diagnostic technologies accessible in all resource settings.
Greiner Bio-One introduces VACUETTE FC Mix Tube for effective glycolysis inhibition
, /in Product News /by callanGreiner Bio-One has introduced VACUETTE FC Mix Tube for effective glycolysis inhibition for precise determination of the in vivo blood sugar content.
The time from collection until separation of plasma and cells, temperature as well as cell count strongly affect glucose levels possibly leading to false low results. Unfortunately, fluoride alone is not able to stabilize the real in-vivo glucose level completely.
VACUETTE FC Mix Tubes are citrated and therefore can help to prevent the initial loss of glucose within the first few hours from collection until fluoride shows its effect. Buffered Na2EDTA, citric acid, sodium citrate and sodium fluoride are used to decrease the pH and block the pH dependent enzymes, which would be active in the initial stage of the glycolysis cascade.
SEKISUI Diagnostics launches OSOM Ultra Plus Flu A&B Test
, /in Product News /by callanSEKISUI Diagnostics has launched the OSOM Ultra Plus Flu A&B Test. The test utilizes traditional lateral flow technology with performance near or exceeding sensitivity of other reader-based tests without using an instrument. It is intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal or nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.
High performance, point-of-care rapid test for the detection of Influenza A&B
IgD Immunoglobulin assays for nephelometry (IMMAGE® and BN™ series) and turbidimetry
, /in Product News /by TRIMERO DIAGNOSTICSTRIMERO Diagnostics offers IVD CE marked assays for testing IgD Immunoglobulins (IgD) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Siemens’ BN™ nephelometric systems.
ERBA Mannheim launches 2nd generation SARS-CoV-2 RT-PCR Assay with room temperature storage
, /in Product News, Corona News /by callanIn response to the ongoing COVID-19 pandemic, Erba Mannheim has launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2.
To overcome challenges in older COVID-19 molecular tests, Erba’s Cambridge(UK)-based development team has engineered a new assay to improve detection and ease of use with a single tube multiplex mastermix, compatible with room-temperature storage and transportation.
The new assay offers 200 copies/ml LoD, using universally trusted gene targets highly specific for SARS-CoV-2 and updated primer sequences to maximise long term performance. Sample types include both nasopharyngeal and oropharyngeal swabs as well as saliva.
Nikhil Vazirani, MD of Erba, said: “We are proud and excited to add a highly sensitive RT-PCR test to our growing range of immunoassay and molecular solutions. The new ErbaMDx SARS-CoV-2 test perfectly complements our successful COVID-19 IgG and IgM ELISA assays to offer customers a state-of-the-art molecular test in addition to antibody testing which will offer clinicians valuable insight into the immune response to infection or vaccination.”
The CE-marked kit will be available through Erba’s global distribution network.
Erba Mannheim, established in over 100 countries, focusses on delivering innovative, affordable and sustainable diagnostic solutions to labs everywhere. The Erba group uses a combination of cutting-edge R&D in 4 continents with efficient low-cost manufacturing to make diagnostic technologies accessible in all resource settings.
IVD Test and Product Development
, /in Advertenties /by 3wmediaBasic Metabolic Panel. STAT.
, /in Advertenties /by 3wmediaTotal bile acids 21 FS – Reliable Assessment of Liver Function
, /in Advertenties /by 3wmediaDisease Specific Real Time micro PCR Chips
, /in Advertenties /by 3wmediaLargest Selection of Critical Care Test Menus and Models
, /in Advertenties /by 3wmediaArctoris appoints three experienced industry executives to Advisory Board
, /in E-News /by 3wmediaArctoris, an Oxford-based research company operating a fully automated drug discovery platform, has appointed three distinguished experts as members of its Advisory Board: Beth J Hoffman PhD, Prof. Khusru Asadullah MD, and Stanley Lapidus.